{
    "Trade/Device Name(s)": [
        "Tyson Bio HS100 Blood Glucose Monitoring System",
        "Tyson Bio HS100-B Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Tyson Bioresearch, Inc.",
    "510(k) Number": "K182046",
    "Predicate Device Reference 510(k) Number(s)": [
        "K170079"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "October 31, 2018",
    "Summary Letter Received Date": "October 31, 2018",
    "Submission Date": "November 28, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Tyson Bio HS100 Blood Glucose Meter",
        "Tyson Bio HS100-B Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor"
    ],
    "Methodologies": [
        "Amperometric detection"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Tyson Bio HS100 and HS100-B Blood Glucose Monitoring Systems using electrochemical biosensor technology for quantitative measurement of glucose in capillary whole blood.",
    "Indications for Use Summary": "Intended for the quantitative measurement of glucose in fresh capillary whole blood from the fingertips, forearm, or palm; for self-testing by people with diabetes at home as an aid to monitor diabetes control effectiveness, not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}